Inflammatory bowel diseases (IBDs) are chronic diseases of unclear etiology that affect over
1 million individuals in the United States and over 2.5 million people in Europe. However …

The inflammatory bowel diseases (IBDs) are among the most closely studied chronic
inflammatory disorders that involve environmental, host genetic, and commensal microbial …

Inflammatory bowel diseases (IBD) are chronic relapsing inflammatory disorders involving
the gastrointestinal (GI) tract, which arise from the confluence of genetic, immunological …

The intestinal microbiota has important metabolic and host-protective functions. Conversely
to these beneficial functions, the intestinal microbiota is thought to play a central role in the …

Inflammatory bowel diseases (IBD) arise from a convergence of genetic risk, environmental
factors, and gut microbiota, where each is necessary but not sufficient to cause disease …

Inflammatory bowel disease is a heterogeneous group of chronic disorders that result from
the interaction of the intestinal immune system with the gut microbiome. Until recently, most …

The intestinal microbiota in inflammatory bowel diseases: ti... : Current Opinion in
Gastroenterology The intestinal microbiota in inflammatory bowel diseases: time to connect …

Inflammatory bowel diseases (IBD) are a group of chronic diseases of increasing worldwide
prevalence characterized by gastrointestinal (GI) inflammation leading to debilitating …

Therapeutic strategies for inflammatory bowel disease (IBD) have increased over the past
decade, but considerable unmet needs remain. Increasingly, patients seek safer, long-term …

Abstract Inflammatory Bowel Disease (IBD) is a chronic relapsing-remitting disease with a
remarkable increase in incidence worldwide and a substantial disease burden. Although the …